Medivolve Inc. MEDVF
OTC PK
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -8.10M | -9.56M | -6.34M | -11.68M | -15.11M |
| Total Depreciation and Amortization | -31.10K | 48.30K | 180.70K | 634.80K | 918.70K |
| Total Amortization of Deferred Charges | 210.40K | 210.40K | 350.70K | 350.70K | 280.00K |
| Total Other Non-Cash Items | 5.82M | 6.77M | 2.97M | 5.60M | 8.92M |
| Change in Net Operating Assets | 1.80M | 937.00K | 117.50K | 3.75M | 1.68M |
| Cash from Operations | -296.00K | -1.60M | -2.72M | -1.34M | -3.32M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -186.90K | -186.90K | -183.00K | -183.00K | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -186.90K | -186.90K | -183.00K | -183.00K | -- |
| Total Debt Issued | 0.00 | 1.20M | 1.20M | 1.20M | 1.20M |
| Total Debt Repaid | -73.90K | -1.51M | -2.22M | -2.53M | -3.35M |
| Issuance of Common Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -54.60K | -231.40K | -755.00K | -991.80K | -1.63M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -537.50K | -2.01M | -3.66M | -2.52M | -4.95M |